1. Home
  2. VANI vs TSI Comparison

VANI vs TSI Comparison

Compare VANI & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

N/A

Current Price

$1.36

Market Cap

119.0M

Sector

Health Care

ML Signal

N/A

Logo TCW Strategic Income Fund Inc.

TSI

TCW Strategic Income Fund Inc.

HOLD

Current Price

$4.36

Market Cap

277.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VANI
TSI
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
277.8M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
VANI
TSI
Price
$1.36
$4.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
207.3K
149.1K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
7.46%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$4.33
52 Week High
$1.92
$5.06

Technical Indicators

Market Signals
Indicator
VANI
TSI
Relative Strength Index (RSI) 48.92 42.48
Support Level $1.26 N/A
Resistance Level $1.55 $4.45
Average True Range (ATR) 0.09 0.03
MACD -0.00 -0.00
Stochastic Oscillator 32.05 36.36

Price Performance

Historical Comparison
VANI
TSI

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a diversified closed-end management investment company. The investment objective of the company is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as banks, beverages, biotechnology, chemicals, commercial services, and others.

Share on Social Networks: